Frequently asked questions
The FOXP1 Medical Research Foundation (FMRF) is a 501(c)(3) nonprofit organization founded by parents to accelerate treatment development for FOXP1 syndrome, a rare neurodevelopmental genetic condition. This page answers the most common questions about FOXP1 syndrome, our research programs, and how to get involved.
About FOXP1 syndrome
What is FOXP1 syndrome?
FOXP1 syndrome is a rare genetic neurodevelopmental condition caused by mutations, deletions, or duplications affecting the FOXP1 gene on chromosome 3. It results in global developmental delay, intellectual disability, and significant speech and language challenges. Most cases arise from de novo (new, not inherited) variants. FOXP1 syndrome affects individuals of all sexes, races, and ethnicities worldwide.
How common is FOXP1 syndrome?
FOXP1 syndrome is considered a rare condition. Because genetic sequencing is still expanding access to diagnosis globally, the true prevalence is not yet fully established. FMRF is actively working to develop formal prevalence estimates as part of its foundational infrastructure work.
What are the main symptoms of FOXP1 syndrome?
The most common features include global developmental delay, intellectual disability, delayed or disordered speech and language, autism features or an autism diagnosis, ADHD, anxiety, and motor challenges such as low muscle tone (hypotonia) in infancy. Vision issues, seizures, sleep problems, and feeding difficulties are also reported. A full symptom overview is available on our What to expect page.
How is FOXP1 syndrome diagnosed?
FOXP1 syndrome is diagnosed through genetic testing—typically whole exome sequencing (WES) or whole genome sequencing (WGS). Many families receive a diagnosis after a child presents with developmental delay or speech delay and standard evaluations prompt genetic workup. A geneticist or genetic counselor typically confirms the diagnosis and guides next steps.
Is FOXP1 syndrome inherited?
The vast majority of cases are de novo, meaning the mutation occurred spontaneously and was not inherited from a parent. In rare cases, a variant can be inherited from a parent who is minimally or mildly affected. Genetic counseling is recommended for families with a confirmed FOXP1 diagnosis.
Does FOXP1 syndrome affect life expectancy?
There is no evidence that FOXP1 syndrome itself shortens life expectancy. Most medical needs are managed through standard clinical care. Many individuals progress in skills throughout their lives with appropriate support, though typically with significant challenges.
What therapies help individuals with FOXP1 syndrome?
Speech-language therapy (especially from clinicians with expertise in motor speech disorders and AAC), occupational therapy, physical therapy, behavioral therapy, and special education supports are among the most impactful interventions. Early intervention is recommended. See our What to expect page for detailed guidance.
Are there any approved treatments or medications for FOXP1 syndrome?
As of 2026, there are no FDA-approved therapeutics specifically targeting the underlying cause of FOXP1 syndrome. Supportive therapies and medications for co-occurring conditions (ADHD, anxiety, epilepsy, etc.) can be helpful. Developing disease-modifying treatments is the central mission of FMRF.
About the FOXP1 Medical Research Foundation
What is the FOXP1 Medical Research Foundation (FMRF)?
FMRF is a 501(c)(3) nonprofit organization (EIN: 39-4407731) founded by parents dedicated to advancing rigorous, innovative medical research to discover treatments—and ultimately a cure—for FOXP1 syndrome.
Who founded FMRF?
FMRF was co-founded by Samit Dasgupta, PhD and Mikhal Roman. Both founders have children with FOXP1 syndrome and are dedicated to developing treatments to help their children and the broader FOXP1 community.
How is FMRF different from the International FOXP1 Foundation (IFF)?
The International FOXP1 Foundation (IFF) is focused on community support, supporting research efforts, and connection for FOXP1 families globally. FMRF’s distinct mission is treatment development—funding and advancing the scientific research needed to bring therapies to patients. The two organizations are collaborative partners, not competitors.
What research programs does FMRF fund or support?
FMRF’s research framework spans five pillars: (1) de-risking research to demonstrate treatability, (2) clinical research including natural history studies, (3) scientific toolkit development such as animal models and iPSC lines, (4) foundational infrastructure including ICD-10 code development and regulatory preparation, and (5) treatment research including novel and repurposed small molecules, ASO therapy, and gene therapy programs. See our Research framework for more.
What treatment approaches is FMRF pursuing?
FMRF is pursuing multiple therapeutic strategies, including antisense oligonucleotide (ASO) upregulation therapy, gene therapy, and novel and repurposed small molecules. FMRF prioritizes approaches with the clearest path to patients and builds on lessons from related monogenic neurodevelopmental disorders.
Is FOXP1 syndrome treatable?
The scientific community believes it is. The FOXP1 gene regulates neuronal development, and emerging evidence from related conditions suggests that restoring or modulating FOXP1 expression—even in older children and adults—may be beneficial. FMRF is funding research specifically designed to demonstrate this and de-risk the path for pharmaceutical investment.
For families
My child was just diagnosed with FOXP1 syndrome. Where do I start?
Start by connecting with a care team that includes a geneticist, developmental pediatrician, and speech-language pathologist with motor speech expertise. Pursue early intervention therapies as quickly as possible. Connect with the FOXP1 community—both FMRF and IFF offer family resources and connections. Our What to Expect page provides a detailed first-steps guide.
Can my child participate in FOXP1 research?
Yes—family participation is critical to advancing research. Families can connect with FMRF through our Contact page to learn about research opportunities, including natural history studies. FMRF works with researchers at leading institutions who are actively seeking participants.
What is AAC and should my child use it?
AAC stands for augmentative and alternative communication—tools that support or replace verbal speech, including picture boards, sign language, and speech-generating devices. Research and clinical experience strongly support AAC use for children with FOXP1 syndrome who have limited speech. AAC does not inhibit speech development; it supports it. Ask your speech-language pathologist for an AAC evaluation.
For researchers and industry
How can researchers partner with FMRF?
FMRF actively seeks collaborations with academic researchers, CROs, and biotech and pharmaceutical companies. We provide access to scientific resources, can facilitate connections to patient families and biospecimens, and offer co-funding and partnership structures. Visit our Opportunities to partner page or contact us at info@foxp1research.org.
What scientific resources does FMRF make available?
FMRF is building and disseminating shared scientific tools including FOXP1 animal models, iPSC lines, and clinical outcome measures. These resources are designed to lower barriers for researchers and accelerate the field. See our Scientific resources page.
Does FOXP1 syndrome have an ICD-10 code?
FMRF is actively working with the IFF to establish a dedicated ICD-10 code for FOXP1 syndrome. A unique disease code is important for clinical documentation, insurance coverage, research funding, and regulatory pathways. This is a current priority for FMRF’s foundational infrastructure work.
Donating and getting involved
How can I donate to FMRF?
Donations can be made online on our Ways to give page. FMRF accepts one-time and recurring gifts, workplace matching, and stock or securities donations. FMRF is a 501(c)(3) organization (EIN: 39-4407731) and all donations are tax-deductible to the extent permitted by law.
How is my donation used?
Donations fund scientific research, scientific toolkit development, clinical studies, and foundational work to advance the field toward treatments. FMRF is committed to transparency and impact-driven allocation of resources.
Can I fundraise on behalf of FMRF?
Yes! FMRF’s community fundraising platform is available on our Fundraising page. Families, friends, and supporters can create personal fundraising webpages for birthdays, awareness campaigns, and events.